Article Information
History
- June 2, 2020.
Article Versions
- You are currently viewing Version 1 of this article (June 2, 2020 - 10:03).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Dami Collier, specialist registrar1,2,*,
- Sonny M. Assennato, post-doctoral researcher3,*,
- Ben Warne, specialist registrar2,4,7,
- Nyarie Sithole, specialist registrar4,
- Katherine Sharrocks, specialist registrar4,
- Allyson Ritchie, post-doctoral researcher3,
- Pooja Ravji, specialist registrar4,
- Matthew Routledge, specialist registrar4,
- Dominic Sparkes, specialist registrar4,
- Jordan Skittrall, specialist registrar4,
- Anna Smielewska, specialist registrar4,
- Isobel Ramsey, specialist registrar4,
- Neha Goel, doctoral student3,
- Martin Curran, Clinical Scientist5,
- David Enoch, consultant microbiologist5,
- Rhys Tassell, POC testing lead6,
- Michelle Lineham, POC team member6,
- Devan Vaghela, specialist registrar4,
- Clare Leong, specialist registrar4,
- Hoi Ping Mok, consultant physician4,
- John Bradley, professor of medicine7,8,
- Kenneth GC Smith, professor of medicine2,7,
- Vivienne Mendoza9,
- Nikos Demiris10,
- Martin Besser11,
- Gordon Dougan, professor2,7,
- Paul J. Lehner, professor of immunology and medicine2,7,
- Hongyi Zhang, consultant microbiologist5,
- Claire S. Waddington, clinical lecturer4,7,
- Helen Lee, CEO3,*,
- Ravindra K. Gupta, professor of clinical microbiology2,4,7,11,*,†,
- and the CITIID-NIHR COVID BioResource Collaboration
- 1Division of Infection and Immunity, University College London, UK. WC1E 6BT
- 2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. CB2 0AW
- 3Diagnostics for the Real World EU Ltd., Chesterford Research Park, UK. CB10 1XL
- 4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
- 5Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, UK. CB2 0QQ
- 6POC Testing, Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. CB2 0QQ
- 7Department of Medicine, University of Cambridge, Cambridge, UK. CB2 0AW
- 8National Institutes for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. CB2 0QQ
- 9NIHR Cambridge Clinical Research Facility, Cambridge, UK. CB2 0QQ
- 10Department of Statistics, Athens University of Economics and Business, 28is Oktovriou 76, 104 34, Athens, Greece
- 11Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. CB2 0QQ
- 12Africa Health Research Institute, Durban, 4001. South Africa
- ↵†
Corresponding author:
Ravindra K Gupta, Professor of Clinical Microbiology, Cambridge Institute for Therapeutic Immunology and Infectious Diseases, Jeffrey Cheah Biomedical Centre, University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, Tel: +44 1223 331491, EMAIL: rkg20{at}cam.ac.uk The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non-exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in BMJ editions and any other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our licence.
↵* Equal contribution